Shrimp Disease Diagnostics Market

As disease diagnosis and subsequent treatment continue being the key cornerstones in aquaculture, seafood farmers are more than keen on integrating state-of-the-art improvements into their health management paradigms.Disease management has always been a bright spot in aquaculture, as intensively cultured seafood products remain naturally susceptible to viral infections. As ?disease-free? certifications started making their way to the prominent requisites for successful transactions in the shrimp landscape, adoption of effective diagnostics became highly imperative for shrimp suppliers to ensure product integrity.
Shrimp Disease Diagnostics Market contains market size and forecasts of Shrimp Disease Diagnostics in Global, including the following market information:
Global Shrimp Disease Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Shrimp Disease Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
WSSV Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Shrimp Disease Diagnostics include HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, SUREBIO and Auro Biotechnologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Shrimp Disease Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Shrimp Disease Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Shrimp Disease Diagnostics Market Segment Percentages, by Type, 2021 (%)
WSSV
TSV
YHV/GAV
IHHNV
HPV
MBV
IMNV
NHP-B
MoV
Others
Global Shrimp Disease Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Shrimp Disease Diagnostics Market Segment Percentages, by Application, 2021 (%)
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Global Shrimp Disease Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Shrimp Disease Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Shrimp Disease Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Shrimp Disease Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD.
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
SUREBIO
Auro Biotechnologies